Vaccines

Travel vaccinations that must always be given on the NHS:

• Hepatitis A - first and second dose
• Combined hepatitis A and B - all doses
• Typhoid - first and any subsequent doses
• Combined hepatitis A and typhoid - first dose (second dose monovalent hepatitis A)
• Tetanus, diphtheria and polio given as combined Td/IPV vaccine
• Cholera

Travel vaccinations that cannot be given on the NHS:

• Yellow fever (must be given by registered centre)
• Japanese encephalitis
• Tick-borne encephalitis
• Rabies

Travel vaccinations that can either be given on the NHS or privately:

• Hepatitis B (monovalent) any dose

Meningitis ACWY (quadrivalent meningococcal meningitis vaccine; A,C, W135, Y)

The Interix B (Hepatitis B (rDNA) vaccine adsorbed (HPV)) or Twinrix (Hepatitis A (inactivated) and Hepatitis B (rDNA) vaccine (adsorbed)) exceptional schedules (0, 7, 21 days, 12 months)are suitable for use in adults aged 18 years or older, in exceptional circumstances (e.g. travel to high-endemicity area within 1 month).

Alternatively, the Engerix B Accelerated schedule (0, 1, 2, 12 months) can be used in all ages.

Try our Travel Vaccine Selector Tool to find out which vaccine doses you can give in the time before your patient travels abroad. Simply input some patient details, the disease areas which the patient will be exposed to whilst travelling and their date of departure in order to generate a recommendation of vaccines and dosage schedules.

If the traveller arrives too late to complete the course of vaccination prior to travel, initiation of the course may provide some protection with completion of their course of vaccination being possible on their return. Please consult the SmPC of the vaccine for further information.

Find out how to order GSK vaccines online through vaccines.co.uk on our ‘How to order...’ page.

On vaccines.co.uk, you can order GSK vaccines easily and securely. Alternatively, call our sales team on 0808 100 9997 (Please note: your call will be answered by a promotional sales representative).

A plastic bag is now used and provides a number of benefits;

• It gives visibility of the contents at all times which adds a level of assurance that the correct product is being delivered to the customer
• The bags are clearly labelled as containing ‘chilled’ product and include advice regarding storage
• The bags are easier to transfer directly to a fridge
• Using a plastic bag is lighter and more flexible in holding the various chill products that we distribute
• It also leaves less of an environmental footprint and is more efficient

The plastic bags are stored in the fridge unit which is a robust standalone compartment inside the vehicle and complies with all MHRA guidelines.

Fluarix Tetra is the UK’s first quadrivalent influenza vaccine which protects against 2 A strains and both B lineages, Fluarix Tetra provides broader protection against influenza than current trivalent vaccines. GSK are no longer providing Fluarix (influenza vaccine – split virion, inactivated), a trivalent flu vaccine which only protects against 2 A strains and one of the possible B lineages.

Fluarix Tetra is indicated for use in adults and children from 3 years of age.

For more information on Fluarix and Fluarix Tetra, you can speak to a member of our promotional flu team by calling 0808 100 9997.

GSK have discontinued the ACWY Vax and introduced the conjugated vaccine, Nimenrix▼(meningococcal polysaccharide groups A, C, W135 and Y vaccine), to the market.

GSK Vaccines are able to supply a conjugated ACWY vaccine called Nimenrix in a single vial + PFS presentation. In Nimenrix, the A, C, W135 and Y polysaccharides are conjugated to tetanus toxoid to enhance the immune system. There are also alternative meningococcal ACWY containing vaccines available in the UK however GSK cannot make specific recommendations for any particular patient. Patients should consult their GP, nurse or treating clinician for advice.

Nimenrix protects individuals against invasive meningococcal diseases caused by Neisseria meningitidis group A, C, W135 and Y.

Nimenrix is a conjugate vaccine that is indicated for use against invasive meningococcal disease caused by Neisseria meningitidis serogroups A, C, W135 and Y, and can be used in individuals from one year of age, adolescents and adults as a one dose vaccine.[1]